Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

Vitamin D and its Supplementation: Where is the Evidence and Should …

UCSF School of Medicine

C. J. Rosen

Vitamin D: How Does It Work? What's the “Right” Level?

The North American Thrombosis Forum (NATF)

C. J. Rosen

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Osteoporosis Medications: When to Continue and When to Stop?

Sonali Khandelwal

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Osteoporosis & Vitamin D: Does Vitamin D Reduce Falls/Fractures in t…

John Tayek

Calcium and Vitamin D Supplementation to Prevent and Manage Osteopor…

ACR Convergence 2021 Coverage

N. Lane

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Weightloss in Menopause

Susan Brian

Tirzepatide Updates

Diana Isaacs

Early Detection & The Delay and Prevention of T1D

Thomas Blevins

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian